Oleson Erik B, Hamilton Lindsey R, Gomez Devan M
Department of Psychology, University of Colorado Denver, Denver, CO, United States.
Department of Biomedical Sciences, Marquette University, Milwaukee, WI, United States.
Front Synaptic Neurosci. 2021 Jun 10;13:660218. doi: 10.3389/fnsyn.2021.660218. eCollection 2021.
Motivational and attentional processes energize action sequences to facilitate evolutionary competition and promote behavioral fitness. Decades of neuropharmacology, electrophysiology and electrochemistry research indicate that the mesocorticolimbic DA pathway modulates both motivation and attention. More recently, it was realized that mesocorticolimbic DA function is tightly regulated by the brain's endocannabinoid system and greatly influenced by exogenous cannabinoids-which have been harnessed by humanity for medicinal, ritualistic, and recreational uses for 12,000 years. Exogenous cannabinoids, like the primary psychoactive component of cannabis, delta-9-tetrahydrocannabinol, produce their effects by acting at binding sites for naturally occurring endocannabinoids. The brain's endocannabinoid system consists of two G-protein coupled receptors, endogenous lipid ligands for these receptor targets, and several synthetic and metabolic enzymes involved in their production and degradation. Emerging evidence indicates that the endocannabinoid 2-arachidonoylglycerol is necessary to observe concurrent increases in DA release and motivated behavior. And the historical pharmacology literature indicates a role for cannabinoid signaling in both motivational and attentional processes. While both types of behaviors have been scrutinized under manipulation by either DA or cannabinoid agents, there is considerably less insight into prospective interactions between these two important signaling systems. This review attempts to summate the relevance of cannabinoid modulation of DA release during operant tasks designed to investigate either motivational or attentional control of behavior. We first describe how cannabinoids influence DA release and goal-directed action under a variety of reinforcement contingencies. Then we consider the role that endocannabinoids might play in switching an animal's motivation from a goal-directed action to the search for an alternative outcome, in addition to the formation of long-term habits. Finally, dissociable features of attentional behavior using both the 5-choice serial reaction time task and the attentional set-shifting task are discussed along with their distinct influences by DA and cannabinoids. We end with discussing potential targets for further research regarding DA-cannabinoid interactions within key substrates involved in motivation and attention.
动机和注意力过程为行动序列提供能量,以促进进化竞争并提升行为适应性。数十年的神经药理学、电生理学和电化学研究表明,中脑皮质边缘多巴胺(DA)通路调节动机和注意力。最近,人们认识到中脑皮质边缘DA功能受到大脑内源性大麻素系统的严格调控,并受到外源性大麻素的极大影响——人类利用外源性大麻素进行药用、仪式用和娱乐用已有12000年历史。外源性大麻素,如大麻的主要精神活性成分Δ9-四氢大麻酚,通过作用于天然存在的内源性大麻素的结合位点来产生其效果。大脑的内源性大麻素系统由两种G蛋白偶联受体、这些受体靶点的内源性脂质配体以及参与其产生和降解的几种合成和代谢酶组成。新出现的证据表明,内源性大麻素2-花生四烯酸甘油酯是观察DA释放和动机行为同时增加所必需的。而且历史药理学文献表明大麻素信号在动机和注意力过程中均发挥作用。虽然这两种行为在DA或大麻素药物的操控下都已得到仔细研究,但对于这两个重要信号系统之间的前瞻性相互作用却知之甚少。本综述试图总结在旨在研究行为的动机或注意力控制的操作性任务中,大麻素对DA释放调节的相关性。我们首先描述大麻素在各种强化条件下如何影响DA释放和目标导向行为。然后我们考虑内源性大麻素在将动物的动机从目标导向行为转变为寻找替代结果以及形成长期习惯方面可能发挥的作用。最后,我们讨论使用5选连续反应时任务和注意力定势转换任务的注意力行为的可分离特征,以及DA和大麻素对它们的不同影响。我们最后讨论了关于动机和注意力相关关键底物内DA-大麻素相互作用的进一步研究的潜在靶点。